| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/21/2004 | EP1439226A2 A nucleic acid antisense sequence to a polynucleotide encoding a polypeptide having heparanese activity |
| 07/21/2004 | EP1439193A2 Antibody directed to polypeptide having heparanase activity |
| 07/21/2004 | EP1439190A1 Growth differentiation factor-5 |
| 07/21/2004 | EP1439185A1 Stabilization of amrubicin hydrochloride |
| 07/21/2004 | EP1439178A1 HETEROCYCLIC COMPOUNDS, OXAZOLE DERIVATIVES, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF |
| 07/21/2004 | EP1439174A1 4-imidazolin-2-one compounds |
| 07/21/2004 | EP1438973A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 07/21/2004 | EP1438971A1 Immunopotentiators in thermotherapy for cancer |
| 07/21/2004 | EP1438583A2 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 07/21/2004 | EP1438434A2 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 07/21/2004 | EP1438412A2 Methods and compositions for inducing tumor-specific cytotoxicity |
| 07/21/2004 | EP1438405A1 Use of a double-stranded ribonucleic acid for specifically inhibiting the expression of a given target gene |
| 07/21/2004 | EP1438404A2 Inhibition of specific histone deacetylase isoforms |
| 07/21/2004 | EP1438393A1 Differentiation of whole bone marrow |
| 07/21/2004 | EP1438392A2 Cell populations which co-express cd49c and cd90 |
| 07/21/2004 | EP1438390A2 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression |
| 07/21/2004 | EP1438389A2 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 07/21/2004 | EP1438388A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 07/21/2004 | EP1438386A2 Transmembrane protein differentially expressed in cancer |
| 07/21/2004 | EP1438341A1 Antibody stimulating il-1ra production |
| 07/21/2004 | EP1438340A2 Antibodies against kdr, their production and uses |
| 07/21/2004 | EP1438339A2 Human antibodies that have mn binding and cell adhesion-neutralizing activity |
| 07/21/2004 | EP1438334A2 Identification of specific tumor antigens by means of the selection of cdna libraries with sera |
| 07/21/2004 | EP1438320A1 Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same |
| 07/21/2004 | EP1438319A1 Derivatives of etoposide and analogs, and pharmaceutical compositions containing them |
| 07/21/2004 | EP1438313A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 07/21/2004 | EP1438310A1 Beta-carbolin derivatives as ptp-inhibitors |
| 07/21/2004 | EP1438299A1 Bifunctional chelating agent for actinium |
| 07/21/2004 | EP1438298A1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 07/21/2004 | EP1438296A2 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 07/21/2004 | EP1438295A2 Azole derivatives and pharmaceutical compositions containing them |
| 07/21/2004 | EP1438293A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 07/21/2004 | EP1438291A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 07/21/2004 | EP1438281A2 Functionalized stilbene derivatives as improved vascular targeting agents |
| 07/21/2004 | EP1438104A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 07/21/2004 | EP1438076A1 Radiopharmaceutical agent for the treatment of early stage cancer |
| 07/21/2004 | EP1438074A2 Adjuvant compositions |
| 07/21/2004 | EP1438068A2 Antibody inhibitors of gdf-8 and uses thereof |
| 07/21/2004 | EP1438062A2 Methods and compositions for treating dermal lesions |
| 07/21/2004 | EP1438058A1 Extract of ceratonia siliqua leaves and pods containing polyphenols with antioxidant and antitumor activities |
| 07/21/2004 | EP1438057A2 Pine cone extracts and uses thereof |
| 07/21/2004 | EP1438053A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 07/21/2004 | EP1438052A1 INHIBITORS OF HUMAN PHOSPHATIDYL−INOSITOL 3−KINASE DELTA |
| 07/21/2004 | EP1438050A2 Irinotecan for treatment of cancer |
| 07/21/2004 | EP1438046A2 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 07/21/2004 | EP1438044A1 Bis-heteroaryl alkanes as therapeutic agents |
| 07/21/2004 | EP1438039A2 Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment |
| 07/21/2004 | EP1437944A1 Process for the fractionation of oilseed press cakes and meals |
| 07/21/2004 | EP1320521B1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents |
| 07/21/2004 | EP1289571B1 Prochelators of radiometal labeled molecules |
| 07/21/2004 | EP1254251A4 Neurosteroids as markers for alzheimer's disease |
| 07/21/2004 | EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/21/2004 | EP1144369B1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 07/21/2004 | EP1131316B1 Improved chemical process and pharmaceutical formulation |
| 07/21/2004 | EP1067941B1 Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate |
| 07/21/2004 | EP0932402B1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| 07/21/2004 | EP0635030B1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/neu) RELATED SURFACE ANTIGENS |
| 07/21/2004 | CN1514843A Somatostatin-dopamine chimeric analogs |
| 07/21/2004 | CN1514833A Novel tyrosine kinase inhibitors |
| 07/21/2004 | CN1514824A Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
| 07/21/2004 | CN1514727A Favorable modulation of health-related quality of life and health-related quality-adjusted time-to progression of disease in patients with prostate cancer |
| 07/21/2004 | CN1514688A Oncolytic virus therapy |
| 07/21/2004 | CN1513973A Fatly phospho embrella Pa-I.H bacterial strain and method of culturing fatty phospho embrella and medicine made from its active component |
| 07/21/2004 | CN1513881A Lucid ganoderma spore powder polysaccharide, production method and use |
| 07/21/2004 | CN1513879A Germanium enriced gold needle mushroom polysaccharide and its making metehod and use |
| 07/21/2004 | CN1513878A Antitumour medicine containing recombination bacterial toxin protein complex substance |
| 07/21/2004 | CN1513867A Antisense nucleic acid having inhibiting leukemid cell telomerase activity and its application |
| 07/21/2004 | CN1513866A mRNA antisense nucleic acid with inhibited VEGF expression and its application |
| 07/21/2004 | CN1513852A Plant extract and its application |
| 07/21/2004 | CN1513839A Benzamide kind histon deacetylase inhibiting agent having dissociation and antibred activity and its medicinal preparation |
| 07/21/2004 | CN1513549A Polythylene glycol-interferon alpha foreeze dried preparation |
| 07/21/2004 | CN1513512A Nano-chinese medicine composition for treating primary bronchus lung cancer and its preparation method |
| 07/21/2004 | CN1513459A Freeze-dried powder injection contg. metallic complex of ethylenediamine teramethylene phosphoric acid, and its prepn. method |
| 07/21/2004 | CN1513448A Prepn. of medicine composition contg. garcinolic acid and garcinolic acid compound |
| 07/21/2004 | CN1513440A Use of medicine based on forming embolism in capillary blood vessel utilizing ultrasonic microvesicle contrast-media for treating tumor |
| 07/21/2004 | CN1158386C Polynucleotides isolated from skin cells and methods for their use |
| 07/21/2004 | CN1158298C Antineoplastic compound and its prepn and medicine use |
| 07/21/2004 | CN1158297C Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/21/2004 | CN1158286C Taxane derivatives and processes for preparation thereof |
| 07/21/2004 | CN1158284C Porphyrins and their use |
| 07/21/2004 | CN1158283C 4,5-pyrazinoxindoles as protein kinase inhibitors |
| 07/21/2004 | CN1158282C Camptothecine like compound, its preparing method and medicinal composition containing them |
| 07/21/2004 | CN1158277C Farnesyl transferase inhibitors having piperidine structure and process for preparation thereof |
| 07/21/2004 | CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 07/21/2004 | CN1158274C Benzopyran-containing compounds and method for their use |
| 07/21/2004 | CN1158269C 4-aminothiazole 2 group compound as inhibitors of cyclin-dependent kinases |
| 07/21/2004 | CN1158266C Compounds |
| 07/21/2004 | CN1158096C Cancer and tumor treating capsule and its prepn |
| 07/21/2004 | CN1158091C Chinese medicine composition for treating lung cancer |
| 07/21/2004 | CN1158088C Extract of subprostrate sophora its extracting process and its application |
| 07/21/2004 | CN1158082C Pharmaceutical usage of diosgenin |
| 07/21/2004 | CN1158081C Medicine composition containing active vitamin D compound and its use |
| 07/21/2004 | CN1158079C Compound alkyl camptothecine injection prescription and prepn. process thereof |
| 07/20/2004 | US6765019 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 07/20/2004 | US6765013 Thiazolidinedione derivatives for the treatment of diabetes and other diseases |
| 07/20/2004 | US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
| 07/20/2004 | US6765011 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 07/20/2004 | US6765003 3-Arylsulfonyl-2 (substituted methyl) propanoic acid derivatives as matrix metalloproteinase inhibitors |
| 07/20/2004 | US6764995 Uses as an inhibitor of endothelial cell proliferation, capable of inhibiting angiogenesis and causing tumor regression |
| 07/20/2004 | US6764698 Controlled drug release system of retinoic acid |